You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model

 

Online download statistics by month:

Online download statistics by month: August 2020 to February 2026

AbstractFullPdf
Aug 202016516554
Sep 2020348348128
Oct 202019419460
Nov 202018318268
Dec 202017217241
Jan 202120320381
Feb 202116716753
Mar 202115115154
Apr 202113113137
May 202111111129
Jun 2021969644
Jul 2021838343
Aug 2021656530
Sep 2021959548
Oct 202114214270
Nov 2021858553
Dec 2021626329
Jan 2022646618
Feb 202211511925
Mar 2022768336
Apr 2022707342
May 2022809048
Jun 2022869229
Jul 2022737636
Aug 2022727342
Sep 2022697375
Oct 2022778039
Nov 2022838320
Dec 2022353515
Jan 2023575823
Feb 2023747430
Mar 2023707235
Apr 2023565637
May 2023626343
Jun 2023636333
Jul 2023616234
Aug 2023475222
Sep 2023596022
Oct 2023727222
Nov 2023979837
Dec 2023757541
Jan 2024484931
Feb 2024363829
Mar 2024707458
Apr 2024505229
May 2024636339
Jun 2024757840
Jul 2024676928
Aug 2024737329
Sep 2024363722
Oct 2024676741
Nov 2024727424
Dec 2024899034
Jan 2025969761
Feb 2025949440
Mar 2025687037
Apr 2025989843
May 2025757625
Jun 2025727421
Feb 2026110
Total539654752357